Affluent Medical S.A. (AFME)
Euronext
Closed
Aug 26, 2026
Day's Range
6.5052 wk Range
1.32Overview - AFME - Affluent Medical S.A.
Key Statistics
Valuation
Enterprise Value
128.63M
P/E (Trailing)
‪-17.27‬
P/E (Forward)
‪-6.32‬
PEG Ratio
‪-6.32‬
Price / Sales (TTM)
‪20.96‬
Price / Book
‪5.24‬
EV / EBITDA
‪-9.98‬
Profitability
Profit Margin
‪-279.96%‬
Operating Margin
‪-1,575.56%‬
Return on Assets
‪-16.06%‬
Return on Equity
‪-62.50%‬
Ownership
Shares Outstanding
39.26M
Float
10.96M
Held by Insiders
‪21.86%‬
Held by Institutions
‪60.31%‬
Price stats
Beta
‪0.78‬
50-Day Avg
‪1.78‬
200-Day Avg
‪1.52‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
3 analysts
Average price target
‪€ 3.27‬Market Cap - AFME - Affluent Medical S.A.
Peers - AFME - Affluent Medical S.A.
Peer Comparison
Compared with companies in Medical Devices listed on Euronext.
- AFMEEuronextAffluent Medical S.A.240.50MMarket Cap+76.80%52-week change-19.24P/E (Trailing)‪-279.96%‬Profit Margin
- PHIAEuronextKoninklijke Philips N.V.23.07BMarket Cap-1.06%52-week change20.71P/E (Trailing)‪6.30%‬Profit Margin
- IDLEuronextID Logistics Group SA2.21BMarket Cap-19.62%52-week change37.25P/E (Trailing)‪1.69%‬Profit Margin
- NANOEuronextNanobiotix S.A.1.73BMarket Cap+78.44%52-week change—P/E (Trailing)‪-73.51%‬Profit Margin
- IBABEuronextIon Beam Applications SA462.90MMarket Cap+24.65%52-week change37.71P/E (Trailing)‪2.05%‬Profit Margin
- CVXEuronextCarvolix SA446.84MMarket Cap+73.00%52-week change-17.96P/E (Trailing)‪20.78%‬Profit Margin
- CVCVEuronextZCI Limited317.47MMarket Cap+45.05%52-week change—P/E (Trailing)‪-186.77%‬Profit Margin
Profile Summary - AFME - Affluent Medical S.A.
About
Affluent Medical S.A. is a medical technology company dedicated to the development of innovative healthcare solutions. With a focus on urology and interventional cardiology, the company is at the forefront of creating next-generation implants specifically designed to improve patients’ quality of life. Affluent…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
